Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China-Reference-Cited by-同舟云学术

Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China

Published:2022-04 Issue:4 Volume:175 Page:533-540
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Kang Min¹^ORCID,Yi Yao²^ORCID,Li Yan²,Sun Limei²,Deng Aiping²,Hu Ting²,Zhang Jiayi²,Liu Jun²,Cheng Mingji²,Xie Shen²,Luo Min²,Jiang Jing²,Jiang Yawen³^ORCID,Tang Shixing⁴,He Jianfeng²

Affiliation:

1. School of Public Health, Southern Medical University, and Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China (M.K.)

2. Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China (Y.Y., Y.L., L.S., A.D., T.H., J.Z., J.L., M.C., S.X., M.L., J.J., J.H.)

3. School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China (Y.J.)

4. School of Public Health, Southern Medical University, Guangzhou, China (S.T.).

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference37 articles.

1. Preparing for COVID-19 exit strategies

2. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study

3. COVID-19 vaccines: where we stand and challenges ahead

4. What do we know about China’s covid-19 vaccines?

5. Covid-19: What do we know about Sputnik V and other Russian vaccines?

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of CoronaVac in the prevention of COVID-19, a test-negative case-control study in Brazil;The Brazilian Journal of Infectious Diseases;2024-09

2. Effectiveness of COVID-19 Vaccination against Severe Symptoms and Death Among Geriatric Inpatients: A Retrospective Cohort Study in Macao;Vaccines;2024-08-21

3. BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study;Vaccine;2024-05

4. Clinical outcomes and risk factors for SARS-CoV-2 breakthrough cases following vaccination with BNT162b2, CoronaVac, or ChAdOx1-S: A retrospective cohort study in Malaysia;Heliyon;2024-04

5. Comprehensive evaluation of inactivated SARS-CoV-2 vaccination on sperm parameters and sex hormones;Frontiers in Immunology;2024-02-26